使用生理学基础的药理动力学建模,为卡巴马泽平片制订临床相关的规范
Xiaofeng Wang1, Longjie Li1, Hongyi Yang1
1Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, 201203, China.
The AAPS journal
|May 2, 2025
概括
这项研究使用基于生理学的药理动力学建模在中国建立了卡巴马泽片的临床相关规范. 开发了一种虚拟生物等价性方法,以定义这种狭窄的治疗指数药物的溶解和测试极限.
科学领域:
- 药理动力学和药物新陈代谢
- 制药科学 制药科学
- 计算生物学 计算生物学
背景情况:
- 碳胺 (CBZ) 是一种狭窄的治疗指数药物 (NTID),需要精确的规范.
- 建立临床相关的规范对于药物安全性和有效性至关重要,特别是在多样化的群体中.
研究的目的:
- 在中国人群中建立卡巴马泽 (CBZ) 片的临床相关规范.
- 开发和验证一个虚拟生物等价 (VBE) 方法,使用生理学基础的药理动力学 (PBPK) 建模.
主要方法:
- 集成的PBPK建模与体外溶解和药理动力学 (PK) 数据,以开发体外-体内关系 (IVIVR).
- 使用外部数据验证了IVIVR模型,并进行了参数灵敏度分析.
- 开发并验证了基于PBPK模型的VBE方法.
主要成果:
- 建立了一个经过验证的IVIVR模型,敏感性分析量化了参数对药物吸收的影响.
- VBE方法成功地定义了卡巴马西平片溶解 (Q60分钟≥80%,50%≤Q15分钟≤85%) 和测定 (95%-105%) 的安全空间.
结论:
- 该研究提供了基于PBPK模型的方法,用于为NTIDs设定临床相关的规范.
- 这项研究为确保卡巴马西片的质量和治疗性能提供了有价值的参考资料.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
33
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
33
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
23
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
23
Model Approaches for Pharmacokinetic Data: Physiological Models
26
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
26
Pharmacokinetic Models: Overview
531
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
531
Physiological Pharmacokinetic Models: Assumption with Protein Binding
29
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
29
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
54
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
54

![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)
